JBS (NYSE: JBS)

$13.82+1.99%today

Brazilian ADR trading on the NYSE, priced in US dollars.

Market Cap: $14.80B
P/E (TTM): 12.9x
P/B: 1.8x
EPS (TTM): $1.07
Dividend Yield: 9.71%
52-Week Range: $11.49 – $18.65
Volume: 5.20M
Previous Close: $13.55

TTM = trailing twelve months — the most recent 12 months (a rolling window), used for P/E, EPS and dividends. On the tables and charts below, the in-progress current year appears as a “Last 12M” column labelled with the quarter range it covers.

Performance

Today

+1.99%

1 Week

+2.83%

1 Month

+12.54%

YTD

-4.16%

1 Year

-11.69%

5 Years

—

About JBS

US Ticker: JBS
B3 Ticker: JBSS3
Exchange: NYSE
Currency: USD
Sector: Consumer Defensive
Industry: Packaged Foods
Headquarters: Amstelveen, Netherlands
Employees: 283,000
CEO: Mr. Gilberto Tomazoni
Founded: 1953

JBS N.V., together with its subsidiaries, engages in the processing of animal proteins, encompassing activities related to beef, pork, lamb, and poultry worldwide.

The company is involved in the production and marketing of prepared foods and other related products, as well as operations in leather, collagen, hygiene and beauty products, metal packaging, biodiesel, and other related businesses.

It offers its products under the Seara, Doriana, Pilgrim's, Moy Park, Primo, Friboi, Maturatta, Swift, Ozo, Adaptable Meals, and other brand names.

The company was founded in 1953 and is based in Amstelveen, the Netherlands.

jbsglobal.com

Analyst Ratings

Consensus of 14 Wall Street analysts · sourced from Yahoo Finance

1.6Buy

On a 1–5 scale: 1 = Strong Buy, 3 = Hold, 5 = Sell. Lower is more bullish.

12-Month Price Target

Low

$14.62

Average

$17.92

High

$20.55

The average target is +29.69% above the current price of $13.82.

Financial Results

Revenue, EBITDA and net profit (in USD) with net margin (net profit ÷ revenue).

Financial Health

Margins, leverage and cash-flow quality derived from JBS's income statement, balance sheet and cash flow (absolute figures in USD).

ProfitabilityLeverageGrowth

Overall: Financially Solid

Net Margin: 1.7%
ROE: 15.1%
Rev Growth (YoY): -18.88%
Net Debt / EBITDA: -0.06×
Current Ratio: 1.53×
Interest Coverage: —
Free Cash Flow: 2.97B
Payout Ratio: 92.1%

Income — Margins & Efficiency

Metric	Last 12MQ3'25 – Q2'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014
Revenue	$382,188,938,000	-18.9%	$471,142,859,000	+13.0%	$416,952,002,000	+14.6%	$363,816,537,000	-5.2%	$383,967,833,000	+5.9%	$362,496,009,000	+34.2%	$270,204,212,000	+32.1%	$204,523,575,000	+12.6%	$181,680,244,000	+11.3%	$163,169,981,000	-4.2%	$170,380,526,000	+4.6%	$162,914,526,000	+35.2%	$120,469,719,000
Gross profit	$45,314,121,000	-24.9%	$60,327,321,000	-3.9%	$62,772,967,000	+58.3%	$39,648,997,000	-35.0%	$61,040,634,000	-10.9%	$68,488,314,000	+51.5%	$45,218,323,000	+41.5%	$31,946,351,000	+21.3%	$26,340,190,000	+10.8%	$23,772,232,000	+11.5%	$21,313,826,000	-5.7%	$22,590,313,000	+21.0%	$18,673,372,000
Operating income	$14,690,167,000	-35.1%	$22,628,287,000	-4.8%	$23,763,417,000	+348.2%	$5,302,294,000	-79.0%	$25,293,615,000	-24.2%	$33,350,413,000	+63.1%	$20,449,616,000	+52.1%	$13,448,713,000	+87.9%	$7,157,407,000	+6.4%	$6,728,452,000	+2.2%	$6,584,631,000	-27.8%	$9,120,362,000	+11.4%	$8,188,995,000
EBITDA	$27,862,925,000	-23.1%	$36,209,252,000	+2.3%	$35,385,882,000	+140.4%	$14,718,649,000	-59.1%	$35,977,662,000	-16.3%	$42,975,770,000	+55.3%	$27,670,237,000	+51.3%	$18,286,748,000	+51.0%	$12,106,576,000	+8.7%	$11,140,222,000	-3.2%	$11,512,713,000	-10.0%	$12,789,486,000	+23.5%	$10,352,022,000
Net profit	$6,407,707,000	-42.3%	$11,096,825,000	+15.4%	$9,615,923,000	+1006.3%	-$1,060,972,000	-106.7%	$15,850,117,000	-25.4%	$21,241,929,000	+362.0%	$4,598,311,000	-24.2%	$6,068,368,000	+23981.8%	$25,199,000	-95.3%	$534,202,000	+128.7%	$233,563,000	-95.0%	$4,640,114,000	+127.9%	$2,035,910,000
Gross margin	11.9%	-0.9 p.p.	12.8%	-2.3 p.p.	15.1%	+4.2 p.p.	10.9%	-5.0 p.p.	15.9%	-3.0 p.p.	18.9%	+2.2 p.p.	16.7%	+1.1 p.p.	15.6%	+1.1 p.p.	14.5%	-0.1 p.p.	14.6%	+2.1 p.p.	12.5%	-1.4 p.p.	13.9%	-1.6 p.p.	15.5%
Operating margin	3.8%	-1.0 p.p.	4.8%	-0.9 p.p.	5.7%	+4.2 p.p.	1.5%	-5.1 p.p.	6.6%	-2.6 p.p.	9.2%	+1.6 p.p.	7.6%	+1.0 p.p.	6.6%	+2.6 p.p.	3.9%	-0.2 p.p.	4.1%	+0.3 p.p.	3.9%	-1.7 p.p.	5.6%	-1.2 p.p.	6.8%
EBITDA margin	7.3%	-0.4 p.p.	7.7%	-0.8 p.p.	8.5%	+4.4 p.p.	4.0%	-5.3 p.p.	9.4%	-2.5 p.p.	11.9%	+1.6 p.p.	10.2%	+1.3 p.p.	8.9%	+2.3 p.p.	6.7%	-0.2 p.p.	6.8%	+0.1 p.p.	6.8%	-1.1 p.p.	7.9%	-0.7 p.p.	8.6%
Net margin	1.7%	-0.7 p.p.	2.4%	+0.0 p.p.	2.3%	+2.6 p.p.	-0.3%	-4.4 p.p.	4.1%	-1.7 p.p.	5.9%	+4.2 p.p.	1.7%	-1.3 p.p.	3.0%	+3.0 p.p.	0.0%	-0.3 p.p.	0.3%	+0.2 p.p.	0.1%	-2.7 p.p.	2.8%	+1.2 p.p.	1.7%
Revenue growth (YoY)	-18.9%	-31.9 p.p.	13.0%	-1.6 p.p.	14.6%	+19.9 p.p.	-5.2%	-11.2 p.p.	5.9%	-28.2 p.p.	34.2%	+2.0 p.p.	32.1%	+19.5 p.p.	12.6%	+1.2 p.p.	11.3%	+15.6 p.p.	-4.2%	-8.8 p.p.	4.6%	-30.6 p.p.	35.2%	—	—
Effective tax rate	10.3%	-4.8 p.p.	15.1%	-12.7 p.p.	27.8%	-20.1 p.p.	47.8%	+36.3 p.p.	11.5%	-13.0 p.p.	24.6%	-19.1 p.p.	43.7%	+29.9 p.p.	13.8%	-105.4 p.p.	119.1%	+108.2 p.p.	11.0%	+105.3 p.p.	-94.3%	-129.2 p.p.	34.9%	-7.7 p.p.	42.6%
Interest coverage	—	—	2.57×	-83.5%	15.60×	+353.5%	3.44×	-82.2%	19.28×	-44.1%	34.51×	+510.9%	5.65×	+74.1%	3.24×	+61.4%	2.01×	+35.2%	1.49×	-29.9%	2.12×	-42.8%	3.71×	+24.0%	2.99×

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Balance Sheet — Health & Leverage

Metric	Last 12MQ3'25 – Q2'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014
Net debt	-$1,674,903,000	-101.7%	$100,603,322,000	-83.8%	$619,425,295,000	+42.9%	$433,532,702,000	+375.2%	$91,227,010,000	+13.5%	$80,371,452,000	+47.7%	$54,432,452,000	+9.5%	$49,720,983,000	+3.3%	$48,127,977,000	+6.3%	$45,283,343,000	-3.5%	$46,904,792,000	-0.3%	$47,038,738,000	+48.3%	$31,710,612,000
Net Debt / Equity	-0.04×	-101.9%	2.10×	-6.0%	2.24×	+9.9%	2.03×	+3.4%	1.97×	+8.1%	1.82×	+34.3%	1.36×	-19.1%	1.68×	-10.6%	1.88×	+0.6%	1.86×	-11.1%	2.10×	+24.9%	1.68×	+26.3%	1.33×
Net Debt / EBITDA	-0.06×	-102.2%	2.78×	-84.1%	17.50×	-40.6%	29.45×	+1061.6%	2.54×	+35.6%	1.87×	-4.9%	1.97×	-27.6%	2.72×	-31.6%	3.98×	-2.2%	4.06×	-0.2%	4.07×	+10.8%	3.68×	+20.1%	3.06×
Debt / Equity	0.04×	-98.4%	2.63×	-12.8%	3.01×	+18.4%	2.54×	+13.0%	2.25×	-4.1%	2.35×	+27.1%	1.85×	-8.4%	2.02×	-9.4%	2.22×	-5.2%	2.35×	-6.6%	2.51×	+7.0%	2.35×	+40.0%	1.68×
Current ratio	1.53×	-4.0%	1.60×	+8.8%	1.47×	-10.5%	1.64×	+14.0%	1.44×	+2.6%	1.40×	-5.4%	1.48×	+0.6%	1.47×	-13.8%	1.71×	+38.0%	1.24×	+21.7%	1.02×	-18.0%	1.24×	-17.8%	1.51×
Return on equity (ROE)	15.1%	-8.1 p.p.	23.2%	+19.7 p.p.	3.5%	+4.0 p.p.	-0.5%	-34.7 p.p.	34.2%	-13.9 p.p.	48.1%	+36.7 p.p.	11.5%	-9.0 p.p.	20.5%	+20.4 p.p.	0.1%	-2.1 p.p.	2.2%	+1.2 p.p.	1.0%	-15.5 p.p.	16.6%	+8.0 p.p.	8.5%
Return on assets (ROA)	14.0%	+9.5 p.p.	4.5%	+3.9 p.p.	0.6%	+0.7 p.p.	-0.1%	-7.7 p.p.	7.6%	-2.6 p.p.	10.2%	+7.4 p.p.	2.8%	-2.0 p.p.	4.8%	+4.8 p.p.	0.0%	-0.5 p.p.	0.5%	+0.3 p.p.	0.2%	-3.6 p.p.	3.8%	+1.3 p.p.	2.5%
Book value / share	$41.64	-7.1%	$44.80	-64.1%	$124.85	+30.0%	$96.06	+367.3%	$20.56	+15.5%	$17.80	+17.8%	$15.11	+35.9%	$11.12	+15.6%	$9.62	+12.7%	$8.54	+4.3%	$8.19	-15.4%	$9.67	+16.7%	$8.28

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Net Debt & Leverage

Free Cash Flow

Margins

Dividend Payout Ratio

Capex ÷ Revenue

Cash Conversion (operating cash flow ÷ net income)

Ratios computed from company financial statements. Net Debt = total debt − cash & equivalents; FCF = operating cash flow − capital expenditure; absolute values in USD.

Valuation & Dividends

P/E Ratio History

Dividend History

This year (YTD) $1.00/share · yield 7.24%

Dividends and yield from Yahoo Finance (per ADR share, in US dollars). The current-year figures are calendar year-to-date (dividends actually paid this year), not the trailing 12 months.

Listings

JBS trades on 2 exchanges. Prices on this page are the NYSE ADR (JBS).

Exchange	Ticker	Currency
NYSEpriced here	JBS	USD
B3 (São Paulo)	JBSS3	BRL

Frequently Asked Questions

Why hold JBS JBS ADR instead of local B3 JBSS3 shares?

Buying directly on Brazil’s B3 exchange means opening a local brokerage account, converting currency and dealing with Brazilian tax paperwork. ADRs remove that friction: they settle in dollars, follow US market hours, and report in formats foreign investors already understand.

The trade-off is that an ADR’s price reflects two moving parts: (1) the underlying share price, quoted in reais on the B3, and (2) the USD/BRL exchange rate. Because of that second part, a rising company can still deliver a flat, or even negative, dollar return if the real weakens against the dollar. The same applies to ETFs: funds such as EWZ, EWZS and FLBR bundle dozens of these companies into a single ticker for instant diversification, but their dollar value still moves with the real.

Where is JBS listed?

JBS trades on 2 exchanges. The line quoted on this page is NYSE in the United States (JBS, US dollars). It also trades on B3 (São Paulo) in Brazil (JBSS3, Brazilian reais).

On how many exchanges does JBS trade?

2. NYSE — JBS (USD) · B3 (São Paulo) — JBSS3 (BRL). Prices shown on this page are the NYSE line, JBS.

What is JBS' primary listing?

JBS' primary listing is on the B3 in Brazil, where the shares trade as JBSS3 in reais — the company's home market. The NYSE line quoted on this page is an ADR over those same shares: it gives you the asset in US dollars, on US market hours, without opening a Brazilian brokerage account or trading in reais.

What is the difference between JBS and JBSS3?

They are the same company and, economically, the same asset. JBSS3 is the original Brazilian share, listed on the B3 and quoted in reais. JBS is an American Depositary Receipt over that share, listed on the NYSE and quoted in US dollars — a wrapper whose purpose is to give foreign investors access to the Brazilian asset without opening an account in Brazil. The JBS price therefore tracks two things: JBSS3 in reais, and the USD/BRL exchange rate.

How can I buy JBS stock in the United States?

JBS is listed on the NYSE under JBS, priced in US dollars. Any US brokerage offering NYSE-listed securities can trade it, with no foreign-account paperwork and no currency conversion.

As of Fri, Aug 21, 17:00 BRT · Market closed

Financial data last updated: August 21, 2026

← All stocks & ETFs